These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36499643)

  • 21. A Tritordeum-Based Diet for Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Effects on Abdominal Bloating and Psychological Symptoms.
    Riezzo G; Prospero L; Orlando A; Linsalata M; D'Attoma B; Ignazzi A; Giannelli G; Russo F
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study.
    Bellini M; Gambaccini D; Bazzichi L; Bassotti G; Mumolo MG; Fani B; Costa F; Ricchiuti A; De Bortoli N; Mosca M; Marchi S; Rossi A
    Tech Coloproctol; 2017 Jun; 21(6):451-459. PubMed ID: 28567692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
    Shi H; Niu Y; Huang Q; Yang ZM; Yang L
    Zhongguo Zhen Jiu; 2021 Sep; 41(9):984-90. PubMed ID: 34491647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial.
    Khalighi Sikaroudi M; Mokhtare M; Shidfar F; Janani L; Faghihi Kashani A; Masoodi M; Agah S; Dehnad A; Shidfar S
    EXCLI J; 2020; 19():652-667. PubMed ID: 33013260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
    Altomare A; Di Rosa C; Imperia E; Emerenziani S; Cicala M; Guarino MPL
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33946961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable Bowel Syndrome and Diarrhea.
    Eswaran S; Chey WD; Jackson K; Pillai S; Chey SW; Han-Markey T
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1890-1899.e3. PubMed ID: 28668539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.
    Hillestad EMR; Steinsvik EK; Teige ES; Rasmussen SH; Brønstad I; Lundervold A; Hausken T; Hanevik K; Lied GA; Berentsen B
    Neurogastroenterol Motil; 2024 Jul; 36(7):e14814. PubMed ID: 38689453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and gastric mucosal 5-hydroxytryptamine concentrations following cold water intake in patients with diarrhea-predominant irritable bowel syndrome.
    Zuo XL; Li YQ; Yang XZ; Guo M; Guo YT; Lu XF; Li JM; Desmond PV
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2330-7. PubMed ID: 18265445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.
    Brown PM; Drossman DA; Wood AJ; Cline GA; Frazier KS; Jackson JI; Bronner J; Freiman J; Zambrowicz B; Sands A; Gershon MD
    Gastroenterology; 2011 Aug; 141(2):507-16. PubMed ID: 21684281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea.
    Huang HL; Zhu JQ; Yang LS; Wu Q; Shou DW; Chen HT; Ma J; Li YQ; Xu HM; Zhou YJ
    Oxid Med Cell Longev; 2022; 2022():5121496. PubMed ID: 36187337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of associations among dietary tryptophan, microbiome composition and function, and symptom severity in irritable bowel syndrome.
    Plantinga AM; Kamp KJ; Wu Q; Chen L; Yoo L; Burr RL; Cain KC; Raftery D; Carnevale Neto F; Badu S; So SY; Savidge T; Shulman RJ; Heitkemper MM
    Neurogastroenterol Motil; 2023 May; 35(5):e14545. PubMed ID: 36780542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
    World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome.
    Houghton LA; Atkinson W; Whitaker RP; Whorwell PJ; Rimmer MJ
    Gut; 2003 May; 52(5):663-70. PubMed ID: 12692050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mind-regulating and spleen-strengthening needling technique improves abdominal hypersensitivity and emotion by enhancing functional connectivity between hippocampus and brain regions in diarrhea-predominant irritable bowel syndrome patients].
    Geng H; Weng SJ; Zhao TT; Chen L; Wu XL; Zhou JL; Sun JH; Pei LX
    Zhen Ci Yan Jiu; 2021 Apr; 46(4):318-25. PubMed ID: 33931998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
    Chojnacki C; Walecka-Kapica E; Lokieć K; Pawłowicz M; Winczyk K; Chojnacki J; Klupińska G
    Endokrynol Pol; 2013; 64(2):114-20. PubMed ID: 23653274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.